[1] GUSEV E, SARAPULTSEV A. Atherosclerosis and inflammation: insights from the theory of general pathological processes[J]. Int J Mol Sci, 2023, 24(9): 7910. [2] WANG L, HONG W, ZHU H, et al. Macrophage senescence in health and diseases[J]. Acta Pharm Sin B, 2024, 14(4): 1508-1524. [3] MADAUDO C, COPPOLA G, PARLATI A L M, et al. Discovering inflammation in atherosclerosis: insights from pathogenic pathways to clinical practice[J]. Int J Mol Sci, 2024, 25(11): 6016. [4] CHECKOURI E, BLANCHARD V, MEILHAC O. Macrophages in atherosclerosis, first or second row players?[J]. Biomedicines, 2021, 9(9): 1214. [5] MOLNÁR A Á, PÁSZTOR D T, TARCZA Z, et al. Cells in atherosclerosis: focus on cellular senescence from basic science to clinical practice[J]. Int J Mol Sci, 2023, 24(24): 17129. [6] MACHADO-OLIVEIRA G, RAMOS C, MARQUES A R A, et al. Cell senescence, multiple organelle dysfunction and atherosclerosis[J]. Cells, 2020, 9(10): 2146. [7] SADHU S, DECKER C, SANSBURY B E, et al. Radiation-induced macrophage senescence impairs resolution programs and drives cardiovascular inflammation[J]. J Immunol, 2021, 207(7): 1812-1823. [8] BRANCEWICZ J, WÓJCIK N, SARNOWSKA Z, et al. The multifaceted role of macrophages in biology and diseases[J]. Int J Mol Sci, 2025, 26(5): 2107. [9] GAO R, SHI J, LYU Y, et al. ALKBH5 regulates macrophage senescence and accelerates atherosclerosis by promoting CCL5 m6A modification[J]. Arterioscler Thromb Vasc Biol, 2025, 45(6): 928-944. [10] MAHONEY S A, DEY A K, BASISTY N, et al. Identification and functional analysis of senescent cells in the cardiovascular system using omics approaches[J]. Am J Physiol Heart Circ Physiol, 2023, 325(5): H1039-H1058. [11] HAMADA M, TSUNAKAWA Y, JEON H, et al. Role of MafB in macrophages [J]. Exp Anim, 2020, 69(1): 1-10. [12] KATSUOKA F, YAMAMOTO M. Small maf proteins (MafF, MafG, MafK): history, structure and function[J]. Gene, 2016, 586(2): 197-205. [13] HASEGAWA H, WATANABE T, KATO S, et al. The role of macrophage transcription factor MafB in atherosclerotic plaque stability[J]. Atherosclerosis, 2016, 250: 133-143. [14] PENG Y, ZHOU M, YANG H, et al. Regulatory mechanism of M1/M2 macrophage polarization in the development of autoimmune diseases[J]. Mediators Inflamm, 2023, 2023: 8821610. [15] KIKUCHI K, IIDA M, IKEDA N, et al. Macrophages switch their phenotype by regulating maf expression during different phases of inflammation[J]. J Immunol, 2018, 201(2): 635-651. [16] OOI B K, GOH B H, YAP W H. Oxidative stress in cardiovascular diseases: involvement of Nrf2 antioxidant redox signaling in macrophage foam cells formation[J]. Int J Mol Sci, 2017, 18(11): 2336. [17] ZHU J, FAN J, XIA Y, et al. Potential therapeutic targets of macrophages in inhibiting immune damage and fibrotic processes in musculoskeletal diseases[J]. Front Immunol, 2023, 14: 1219487. [18] HOU P, FANG J, LIU Z, et al. Macrophage polarization and metabolism in atherosclerosis[J]. Cell Death Dis, 2023, 14(10): 691. |